Molecular interaction of Siglecs (sialic acid-binding Ig-like lectins) with sialylated ligands on Trypanosoma cruzi

European Journal of Cell Biology

Volumn 89, Issue 1, 2010, Pages 113-116

  Jacobs, Thomas ^a   Erdmann, Hanna ^a   Fleischer, Bernhard ^a  

^a BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

Author keywords

Sialic acid; Siglecs; Trypanosoma cruzi

Indexed keywords

GLYCOCONJUGATE; LECTIN; PROTOZOAL PROTEIN; SIALIC ACID; SIALIC ACID BINDING IMMUNOGLOBULIN LIKE LECTIN; TRANS SIALIDASE; UNCLASSIFIED DRUG;

ACUTE PHASE RESPONSE; AMASTIGOTE; CHAGAS DISEASE; ENZYME ACTIVITY; HOST PARASITE INTERACTION; HUMAN; IMMUNOMODULATION; LIGAND BINDING; MOLECULAR INTERACTION; NONHUMAN; PARASITE TRANSMISSION; PARASITE VIRULENCE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SHORT SURVEY; SIALYLATION; TRYPANOSOMA CRUZI; TRYPOMASTIGOTE;

ANIMALS; GLYCOCONJUGATES; GLYCOPROTEINS; HUMANS; LECTINS; LIGANDS; N-ACETYLNEURAMINIC ACID; NEURAMINIDASE; PARASITES; TRYPANOSOMA CRUZI;

HEXAPODA; PROTOZOA; TRYPANOSOMA CRUZI;

EID: 73649148004     PISSN: 01719335     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcb.2009.10.006     Document Type: Short Survey

References (46)

1. Aliberti J.C., Cardoso M.A., Martins G.A., Gazzinelli R.T., Vieira L.Q., and Silva J.S. Interleukin-12 mediates resistance to Trypanosoma cruzi in mice and is produced by murine macrophages in response to live trypomastigotes. Infect. Immun. 64 (1996) 1961-1967
2. Ando M., Tu W., Nishijima K., and Iijima S. Siglec-9 enhances IL-10 production in macrophages via tyrosine-based motifs. Biochem. Biophys. Res. Commun. 369 (2008) 878-883
3. Argibay P.F., Di Noia J.M., Hidalgo A., Mocetti E., Barbich M., Lorenti A.S., Bustos D., Tambutti M., Hyon S.H., Frasch A.C.C., and Sanchez D.O. Trypanosoma cruzi surface mucin TcMuc-e2 expressed on higher eukaryotic cells induces human T cell anergy, which is reversible. Glycobiology 12 (2002) 25-32
4. Barrett M.P., Burchmore R.J., Stich A., Lazzari J.O., Frasch A.C., Cazzulo J.J., and Krishna S. The trypanosomiases. Lancet 362 (2003) 1469-1480
5. Belen Carrillo M., Gao W., Herrera M., Alroy J., Moore J.B., Beverley S.M., and Pereira M.A. Heterologous expression of Trypanosoma cruzi trans-sialidase in Leishmania major enhances virulence. Infect. Immun. 68 (2000) 2728-2734
6. Blixt O., Head S., Mondala T., Scanlan C., Huflejt M.E., Alvarez R., Bryan M.C., Fazio F., Calarese D., Stevens J., Razi N., Stevens D.J., Skehel J.J., van Die I., Burton D.R., Wilson I.A., Cummings R., Bovin N., Wong C.H., and Paulson J.C. Printed covalent glycan array for ligand profiling of diverse glycan binding proteins. Proc. Natl. Acad. Sci. USA 101 (2004) 17033-17038
7. Buscaglia C.A., Campo V.A., Frasch A.C., and Di Noia J.M. Trypanosoma cruzi surface mucins: host-dependent coat diversity. Nat. Rev. Microbiol. 4 (2006) 229-236
8. Buschiazzo A., Amaya M.F., Cremona M.L., Frasch A.C., and Alzari P.M. The crystal structur and mode of action of trans-sialidase, a key enzyme in Trypanosoma cruzi pathogenesis. Mol. Cell 10 (2002) 757-768
9. 2+ signaling factor for mammalian cells. J. Biol. Chem. 270 (1995) 5172-5180
10. Carlin A.F., Lewis A.L., Varki A., and Nizet V. Group B streptococcal capsular sialic acids interact with Siglecs (immunglobulin-like lectins) on human leukocytes. J. Bacteriol. 189 (2007) 1231-1237
11. Carlin A.F., Uchiyama S., Chang Y.C., Lewis A.L., Nizet V., and Varki A. Molecular mimicry of host sialylated glycans allows a bacterial pathogen to engage neutrophil Siglec-9 and dampen the innate immune response. Blood 113 (2009) 3333-3336
12. Colli W. Trans-sialidase: a unique enzyme activity discovered in the protozoan Trypanosoma cruzi. FASEB J. 7 (1993) 1257-1264
13. Crocker P.R., Paulson J.C., and Varki A. Siglecs and their roles in the immune system. Nat. Rev. Immunol. 7 (2007) 255-266
14. DosReis G.A., Freire-de-Lima C.G., Nunes M.P., and Lopez M.F. The importance of aberrant T-cell responses in Chagas ́ disease. Trends Parasitol. 21 (2005) 237-243
15. Dvorak J.A. The natural heterogeneity of Trypanosoma cruzi: biological and medical implication. J. Cell. Biochem. 24 (1984) 357-371
16. Frasch A.C. Functional diversity in the trans-sialidase and mucin families in Trypanosoma cruzi. Parasitol. Today 16 (2000) 282-286
17. Frosch S., Kraus S., and Fleischer B. Trypanosoma cruzi is a potent inducer of interleukin-12 production in macrophages. Med. Microbiol. Immunol. 185 (1996) 189-193
18. Erdmann, H., Steeg, C., Koch-Nolte, F., Fleischer B., Jacobs, T., 2009. Sialylated ligands on pathogenic Trypanosoma cruzi interact with Siglec-E (sialic acid-binding Ig-like lectin-E). Cell. Microbiol. (E-pub ahead of print), 10.1111/j.1462-5822.2009.01350.x
19. Golden M.J., and Tarleton R.L. Trypanosoma cruzi: cytokine effects on macrophage trypanocidal activity. Exp. Parasitol. 72 (1991) 391-402
20. Hölscher C. The power of combinatorial immunology: IL-12 and IL-12-related dimeric cytokines in infectious diseases. Med. Microbiol. Immunol. 193 (2004) 1-17
21. Hölscher C., Köhler G., Müller U., Mossmann H., Schaub G.A., and Brombacher F. Defective nitric oxide effector functions lead to extreme susceptibility of Trypanosoma cruzi-infected mice deficient in gamma interferon receptor or inducible nitric oxide synthase. Infect. Immun. 66 (1998) 1208-1215
22. Kumar S., and Tarleton R.L. Antigen-specific Th1 but not Th2 cells provide protection from lethal Trypanosoma cruzi infection in mice. J. Immunol. 166 (2001) 4596-4603
23. Kierszenbaum F. Immunologic deficiency during experimental Chagas ́ disease (Trypanosoma cruzi infection): role of adherent, non-specific esterase-positive splenic cells. J. Immunol. 129 (1982) 2202-2205
24. Lieke T., Gräfe S.E., Klauenberg U., Fleischer B., and Jacobs T. NK cells contribute to the control of Trypanosoma cruzi infection by killing free parasites by perforin-independent mechanisms. Infect. Immun. 72 (2004) 6817-6825
25. Lieke T., Graefe S.E.B., Steeg C., Fleischer B., and Jacobs T. Interaction of NK cells with Trypanosoma cruzi infected fibroblasts. Clin. Exp. Immunol. 145 (2006) 357-364
26. Meyer zum Büschenfelde C., Cramer S., Trumpfheller C., Fleischer B., and Frosch S. Trypanosoma cruzi induces strong IL-12 and IL-18 gene expression in vivo: correlation with interferon-gamma (IFN-gamma) production. Clin. Exp. Immunol. 110 (1997) 378-385
27. Monteiro V.G., Lobato C.S.S., Silva A.R., Medina D.V., de Oliveira M.A., Seabra S.H., de Souza W., and DaMatta R.A. Increased association of Trypanosoma cruzi with sialoadhesin positive mice macrophages. Parasitol. Res. 97 (2005) 380-385
28. Petry K., Nudelmann E., Eisen H., and Hakomori S. Sulfated lipids represent common antigens on the surface of Trypanosoma cruzi and mammalian tissues. Mol. Biochem. Parasitol. 30 (1988) 113-121
29. Ravetch J.V., and Lanier L.L. Immune inhibitory receptors. Science 290 (2000) 84-89
30. Rempel H., Calosing C., Sun B., and Pulliam L. Sialoadhesin expressed on IFN-induced monocytes binds HIV-1 and enhances infectivity. PloS One 3 (2008) e1967
31. Risso M.G., Garbarino G.B., Mocetti E., Campetella O., González Cappa S.M., Buscaglia C.A., and Leguizamón M.S. Differential expression of a virulence factor, the trans-sialidase, by the main Trypanosoma cruzi phylogenetic lineages. J. Infect. Dis. 189 (2004) 2250-2259
32. Saeftel M., Fleischer B., and Hoerauf A. Stage-dependent role of nitric oxide in control of Trypanosoma cruzi infection. Infect. Immun. 69 (2001) 2252-2259
33. Schenkman S., Eichinger D., Pereira M.E., and Nussenzweig V. Structural and functional properties of Trypanosoma trans-sialidase. Annu. Rev. Microbiol. 48 (1994) 299-323
34. Souto R.P., Fernandes O., Macedo A.M., Campbell D.A., and Zingales B. DNA markers define two major phylogenetic lineages of Trypanosoma cruzi. Mol. Biochem. Parasitol. 83 (1996) 141-152
35. Tarleton R.L. Parasite persistence in the aetiology of Chagas ́ disease. Int. J. Parasitol. 21 (2001) 550-554
36. Tarleton R.L. Chagas ́ disease: a role for autoimmunity?. Trends Parasitol. 19 (2003) 447-451
37. Tarleton R.L., and Zhang L. Chagas ́ disease etiology: autoimmunity or parasite persistence?. Parasitol. Today 15 (1999) 94-99
38. Tibayrenc M. Genetic epidemiology of parasitic protozoa and other infectious agents: the need for an integrated approach. Int. J. Parasitol. 28 (1998) 85-104
39. Tomlinson S., Pontes de Carvalho L.C., Vandekerckhove F., and Nussenzweig V. Role of sialic acid in the resistance of Trypanosoma cruzi trypomastigotes to complement. J. Immunol. 153 (1994) 3141-3147
40. Vandekerckhove F., Schenkman S., Pontes de Carvalho L., Tomlinson S., Kiso M., Yoshida M., Hasegawa A., and Nussenzweig V. Substrate specificity of the Trypanosoma cruzi trans-sialidase. Glycobiology 2 (1992) 541-548
41. Van Overtvelt L., Andrieu M., Verhasselt V., Connan F., Choppin J., Vercruysse V., Goldman M., Hosmalin A., and Vray B. Trypanosoma cruzi down-regulates lipopolysaccharide-induced MHC class I on human dendritic cells and impairs antigen presentation to specific CD8+ T lymphocytes. Int. Immunol. 14 (2002) 1135-1144
42. Varki A., and Angata T. Siglecs - the major subfamily of I-type lectins. Glycobiology 16 (2006) 1R-27R
43. Williams-Blangero S., VandeBerg J.L., Blangero J., and Correa-Oliveira R. Genetic epidemiology of Trypanosoma cruzi infection and Chagas disease. Front. Biosci. 8 (2003) e337-e345
44. 1H NMR investigation of sialic acid transfer by the trans-sialidase from Trypanosoma cruzi. Bioorg. Med. Chem. Lett. 10 (2000) 2791-2794
45. Zhang M., and Varki A. Cell surface sialic acids do not affect primary CD22 interactions with CD45 and sIgM, nor the rate of constitutive CD22 endocytosis. Glycobiology 14 (2004) 939-949
46. Zingales B., Stolf B., Souto R., Fernandes O., and Briones M. Epidemiology, biochemistry and evolution of Trypanosoma cruzi lineages based on ribosomal RNA sequences. Mem. Inst. Oswaldo Cruz 94 (1999) 159-164